Entera Bio (ENTX) Payables (2017 - 2026)
Entera Bio's (ENTX) quarterly Payables came in at $274000.0 in Q1 2026, up 104.48% YoY from $134000.0 in Q1 2025, and down 38.84% on a QoQ basis from $448000.0 in Q4 2025.
Entera Bio (ENTX) Payables (2017 - 2026) Analysis & Trends
Entera Bio (ENTX) has 10 years of Payables data on file, last reported at $274000.0 in Q1 2026.
- Quarterly Payables rose 104.48% year-over-year to $274000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $274000.0 (up 104.48% YoY) and the FY2025 annual result came in at $448000.0, up 239.39% from the prior year.
- Payables declined to $274000.0 in Q1 2026, from $448000.0 in the prior quarter.
- In the past five years, Payables ranged from a high of $564000.0 in Q3 2023 to a low of $17000.0 in Q4 2022.
- A 5-year average of $216529.4 and a median of $184000.0 in 2024 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables sank 92.6% — and 2025, when it jumped 455.07%.
- Tracing ENTX's Payables over 5 years: stood at $17000.0 in 2022, then surged by 388.24% to $83000.0 in 2023, then jumped by 59.04% to $132000.0 in 2024, then soared by 239.39% to $448000.0 in 2025, then plunged by 38.84% to $274000.0 in 2026.
- The last three Payables figures came in at $274000.0 (Q1 2026), $448000.0 (Q4 2025), and $216000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 35.57 Mn |
| 10 | Entera Bio | 166.42 Mn | 155.11 Mn | - | 575,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 575,000.00 |
| Mar 31, 2026 | 274,000.00 |
| Dec 31, 2025 | 448,000.00 |
| Sep 30, 2025 | 216,000.00 |
| Jun 30, 2025 | 383,000.00 |
| Mar 31, 2025 | 134,000.00 |
| Dec 31, 2024 | 132,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 69,000.00 |
| Mar 31, 2024 | 66,000.00 |
| Dec 31, 2023 | 83,000.00 |
| Sep 30, 2023 | 564,000.00 |
| Jun 30, 2023 | 240,000.00 |
| Mar 31, 2023 | 150,000.00 |
| Dec 31, 2022 | 17,000.00 |
| Sep 30, 2022 | 413,000.00 |
| Jun 30, 2022 | 109,000.00 |
| Mar 31, 2022 | 199,000.00 |
| Dec 31, 2021 | 166,000.00 |
| Jun 30, 2021 | 1.47 Mn |